Astria

Astria is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of allergic and immunological diseases.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Astria Information

Geographic Data

Astria headquarters map

Address: 75 State Street

City: Boston

State: MA

Zip: 02109

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$110M

Raised Total:

$310M

Metrics

8,705,792Website Global Rank

262Website Monthly Traffic

Twitter Followers

Description

Astria is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of allergic and immunological diseases.

Contact Phone:
+16173491971

Contact Email:

Astria went public on 6/29/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/29/2015

IPO Valuation:
$194M

Ticker Symbol:
ATXS

IPO Price:
$12/share

Amount Raised:
$60M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2013 Series B 5 $32.4M SV Health Investors
Advanced Technology Ventures
Lightstone Ventures
MedImmune Ventures
Clarus Ventures
Lightstone Ventures
SV Health Investors
Advanced Technology Ventures
Lightstone Ventures
MedImmune Ventures
Clarus Ventures
Lightstone Ventures
12/2022 Post-IPO Equity $100M
1/2010 Debt Financing $2M
12/2011 Series A 4 $8M SV Health Investors
MedImmune Ventures
Clarus Ventures
Advanced Technology Ventures
4/2010 Series A 4 $39M SV Health Investors
MedImmune Ventures
Clarus Ventures
Advanced Technology Ventures
SV Health Investors
MedImmune Ventures
Clarus Ventures
Advanced Technology Ventures
3/2015 Secondary Market 1 $12.4M Employee Stock Option Fund
Employee Stock Option Fund
1/2010 Debt Financing $2.1M
4/2012 Grant $120k
6/2018 Post-IPO Equity $42M
12/2022 Post-IPO Equity $115M
2/2021 Post-IPO Equity $110M
9/2016 Post-IPO Equity $11.5M
1/2020 Post-IPO Equity $26.5M
12/2010 Series A 4 $14.5M Advanced Technology Ventures
Clarus Ventures
MedImmune Ventures
SV Health Investors
Advanced Technology Ventures
Clarus Ventures
MedImmune Ventures
SV Health Investors
2/2013 Venture Round 4 $9M MedImmune Ventures
Advanced Technology Ventures
SV Health Investors
Clarus Ventures
MedImmune Ventures
Advanced Technology Ventures
SV Health Investors
Clarus Ventures
1/2021 Post-IPO Equity $110M
6/2015 IPO $60M
1/2021 Post-IPO Equity $175.7M
Announced Date Name Price
1/2021 Quellis Biosciences

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research